Outcomes of Hip Arthroscopy in the Medicare Patient: A Growing Population

Although the results of hip arthroscopy in the elderly have been inferior to the results in younger patients, there have recently been some encouraging reports in carefully selected series of older patients. The purpose of this study was to identify the utilization of hip arthroscopy in the Medicare population and to determine the rate and timing of revision arthroscopy and/or total hip arthroplasty (THA) with the goal of identifying risk factors for secondary procedures based on patient demographics, comorbidities and the diagnosis at the time of arthroscopy.

The Medicare Standard Analytic Files were reviewed from 2005-2014 for all patients undergoing hip arthroscopy allowing for minimum 2 year follow-up (100% sample). Patients were tracked through the dataset for the occurrence of an ipsilateral THA or revision hip arthroscopy. Rates and timing of the subsequent procedures were then determined within 6 month intervals. Patients less than 65 years old were excluded. Multivariate logistic regression analysis was performed to determine the impact of patient age, sex, obesity or a diagnosis of hip osteoarthritis on need for revision procedures.

3,320 Medicare patients had a hip arthroscopy during 2005-2014 (0.3% compared to THA). 73 patients (2.2%) underwent reoperation during the follow-up period. Two-thirds (n = 46) of all revision procedures occurred within one year of primary hip arthroscopy. A pre-operative diagnosis of hip osteoarthritis significantly increased the odds of reoperation (OR = 5.3). (Conclusion: Relatively few numbers of Medicare patients underwent hip arthroscopy during the time interval evaluated (0.3% when compared to THA utilization). 2.2% underwent a subsequent revision arthroscopy or THA with many occurring soon after the procedure and for the diagnosis of hip OA demonstrating the need to better define indications in this population. This study should provide baseline utilization and outcome trends for future studies.Level of Evidence: IV.